JP Morgan Downgrades HBT Finl to Underweight, Lowers Price Target to $19

JP Morgan analyst Steven Alexopoulos downgrades HBT Finl (NASDAQ:HBT) from Neutral to Underweight and lowers the price target from $20 to $19.

JP Morgan analyst Steven Alexopoulos downgrades HBT Finl (NASDAQ:HBT) from Neutral to Underweight and lowers the price target from $20 to $19.

Total
0
Shares
Related Posts
Read More

What’s Going On With Longeveron Stock?

Multiple company executives disclosed large stock purchases after the close on Friday. Joshua Hare, Chief Scientific Officer, purchased 297,872 shares. Rock Soffer, director, purchased 276,596 shares and CEO Mohamed Wa'el Ahmed Hashad purchased 21,276 shares. 

LGVN